ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

M. Adamina, S. Bonovas, T. Raine, A. Spinelli, J. Warusavitarne, A. Armuzzi, O. Bachmann, P. Bager, L. Biancone, B. Bokemeyer, P. Bossuyt, J. Burisch, P. Collins, G. Doherty, A. El-Hussuna, P. Ellul, G. Fiorino, C. Frei-Lanter, F. Furfaro, C. GingertP. Gionchetti, J.P. Gisbert, F. Gomollon, M.G. Lorenzo, H. Gordon, T. Hlavaty, P. Juillerat, K. Katsanos, U. Kopylov, E. Krustins, T. Kucharzik, T. Lytras, C. Maaser, F. Magro, J.K. Marshall, P. Myrelid, G. Pellino, I. Rosa, J. Sabino, E. Savarino, L. Stassen, J. Torres, M. Uzzan, S. Vavricka, B. Verstockt, O. Zmora, F. Akyuz, R. Atreya, M.B. De Acosta, D. Bettenworth, European Crohn’s Colitis Organisation (ECCO)

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)155-168
Number of pages14
JournalJournal of Crohn's & Colitis
Volume14
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • anti-tnf therapy
  • crohn's disease
  • evidence-based consensus
  • fecal diversion
  • inflammatory bowel disease [ibd]
  • inflammatory-bowel-disease
  • intersphincteric fistula tract
  • intraabdominal septic complications
  • postoperative complications
  • pouch-anal anastomosis
  • surgery
  • to-end anastomosis
  • vedolizumab-treated patients
  • INTERSPHINCTERIC FISTULA TRACT
  • EVIDENCE-BASED CONSENSUS
  • POSTOPERATIVE COMPLICATIONS
  • inflammatory bowel disease [IBD]
  • FECAL DIVERSION
  • VEDOLIZUMAB-TREATED PATIENTS
  • ANTI-TNF THERAPY
  • Crohn's disease
  • INTRAABDOMINAL SEPTIC COMPLICATIONS
  • INFLAMMATORY-BOWEL-DISEASE
  • TO-END ANASTOMOSIS
  • POUCH-ANAL ANASTOMOSIS

Cite this